ZLAB Form 4: Du Ying Executes Options at $0.60 and Sells ADS at ~$34–$35
Rhea-AI Filing Summary
Du Ying, Chairperson & CEO of Zai Lab Ltd (ZLAB), reported option exercises and open-market sales under a Rule 10b5-1 plan. The Form 4 shows acquisitions (code M) on 08/12/2025 and 08/13/2025 of 50,000 and 46,387 American Depositary Shares (ADS) equivalents at a stated price of $0.60 (reflecting stock options). The reporting person sold the same amounts on those dates under the 10b5-1 plan for weighted average prices of $34.2511 and $35.4687 respectively. Following the transactions the filing reports 536,962 ADS beneficially owned. The filing notes the stock options fully vested on 10/22/2020 and the 10b5-1 plan was adopted on 11/20/2024.
Positive
- Transactions executed under a Rule 10b5-1 plan, indicating preplanned and documented insider trading activity.
- Stock options fully vested as of 10/22/2020, showing no recent acceleration or special vesting disclosed in this filing.
- Reporting person retains substantial ownership with 536,962 ADS beneficially owned after the transactions.
Negative
- Insider sold a total of 96,387 ADS equivalents (50,000 and 46,387) on 08/12/2025 and 08/13/2025, which is material selling activity.
- Weighted average sale prices were $34.2511 and $35.4687, indicating the insider realized significant proceeds from the sales.
Insights
TL;DR: Insider exercised long-held options and sold shares via a documented 10b5-1 plan, showing routine executive liquidity and compliance.
The Form 4 discloses that Du Ying exercised stock options with a $0.60 exercise price and concurrently sold equivalent ADS amounts on 08/12/2025 and 08/13/2025 under a Rule 10b5-1 plan adopted 11/20/2024. The filing states the options fully vested in 2020, which reduces governance concerns over opportunistic timing. Use of a 10b5-1 plan and attorney-in-fact signature indicate procedural adherence and preplanned execution rather than ad hoc insider trading.
TL;DR: Insider sales were material in size but appear executed through a pre-established plan; net ownership remains substantial.
The transactions consist of 96,387 ADS equivalents sold at weighted average prices of $34.2511 and $35.4687 and reporting of 536,962 ADS beneficially owned after the trades. Exercising options at $0.60 and immediate sales generated realized proceeds at market prices noted in the filing. These are straightforward option exercises and sales; the filing provides weighted-average sale prices and offers to furnish per-price details to SEC staff or holders, supporting transparency for investors.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (Right to Buy) | 46,387 | $0.00 | -- |
| Exercise | American Depositary Shares | 46,387 | $0.60 | $28K |
| Sale | American Depositary Shares | 46,387 | $35.4687 | $1.65M |
| Exercise | Stock Options (Right to Buy) | 50,000 | $0.00 | -- |
| Exercise | American Depositary Shares | 50,000 | $0.60 | $30K |
| Sale | American Depositary Shares | 50,000 | $34.2511 | $1.71M |
Footnotes (1)
- Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024. Reflects a weighted average sale price of $34.2511 per share, at prices ranging from $33.70 to $34.60 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Reflects a weighted average sale price of $35.4687 per share, at prices ranging from $34.845 to $35.80 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. The Stock Options fully vested as of October 22, 2020.
